Pro: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?
作者信息
Faraday Nauder
机构信息
Department of Anesthesiology and Critical Care Medicine, Johns Hopkins Medical Institutions, Baltimore, MD 21287, USA.
出版信息
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):112-3. doi: 10.1053/j.jvca.2005.10.006.
Abstract
摘要
相似文献
1
Pro: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):112-3. doi: 10.1053/j.jvca.2005.10.006.
2
Con: Should aspirin be continued after cardiac surgery in the setting of thrombocytopenia?
J Cardiothorac Vasc Anesth. 2006 Feb;20(1):114-6. doi: 10.1053/j.jvca.2005.10.007.
3
Thrombocytopenia corrected by warfarin in antiphospholipid syndrome.
J Rheumatol. 1996 Apr;23(4):769-71.
4
Incidence and prognostic significance of thrombocytopenia developed during acute coronary syndrome in contemporary clinical practice.
Circulation. 2009 May 12;119(18):2454-62. doi: 10.1161/CIRCULATIONAHA.108.827162. Epub 2009 Apr 27.
5
Cardiac surgery in a patient with severe thrombocytopenia: how low is too low?
Ann Card Anaesth. 2013 Jul-Sep;16(3):215-7. doi: 10.4103/0971-9784.114258.
6
7
8
Heparin resistance and increased platelet activation in coronary surgery patients treated with enoxaparin preoperatively.
Eur J Cardiothorac Surg. 2006 Jun;29(6):933-40. doi: 10.1016/j.ejcts.2006.02.007. Epub 2006 May 3.
9
引用本文的文献
1
Aspirin to target arterial events in chronic kidney disease (ATTACK): study protocol for a multicentre, prospective, randomised, open-label, blinded endpoint, parallel group trial of low-dose aspirin vs. standard care for the primary prevention of cardiovascular disease in people with chronic kidney disease.
Trials. 2022 Apr 21;23(1):331. doi: 10.1186/s13063-022-06132-z.
2
Risks and benefits of giving early Aspirin within 6 hours of CABG: A retrospective analysis.
Pak J Med Sci. 2017 Jan-Feb;33(1):106-110. doi: 10.12669/pjms.331.11563.
3
Does Early Post-operative Administration of Aspirin Influence the Risk of Bleeding After Coronary Artery Bypass Graft Surgery? A Prospective Observational Study.
Med Arch. 2015 Dec;69(6):381-3. doi: 10.5455/medarh.2015.69.381-383.
4
Antiplatelet therapy and percutaneous coronary intervention in patients with acute coronary syndrome and thrombocytopenia.
Tex Heart Inst J. 2010;37(3):336-40.
本文引用的文献
1
Functional and biochemical evaluation of platelet aspirin resistance after coronary artery bypass surgery.
Circulation. 2003 Aug 5;108(5):542-7. doi: 10.1161/01.CIR.0000081770.51929.5A. Epub 2003 Jul 21.
2
Aspirin and mortality from coronary bypass surgery.
N Engl J Med. 2002 Oct 24;347(17):1309-17. doi: 10.1056/NEJMoa020798.
3
Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients.
BMJ. 2002 Jan 12;324(7329):71-86. doi: 10.1136/bmj.324.7329.71.
4
Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation.
N Engl J Med. 2001 Aug 16;345(7):494-502. doi: 10.1056/NEJMoa010746.
5
Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes.
JAMA. 2000 Sep 27;284(12):1549-58. doi: 10.1001/jama.284.12.1549.
6
7
8
Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.
N Engl J Med. 1984 Jan 26;310(4):209-14. doi: 10.1056/NEJM198401263100401.
9
The effect of antiplatelet therapy on saphenous vein coronary artery bypass graft patency.
Circulation. 1983 Sep;68(3 Pt 2):II218-21.
10
Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.
Circulation. 1989 Nov;80(5):1190-7. doi: 10.1161/01.cir.80.5.1190.
Zotero 插件